deflazacort has been researched along with Body Weight in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.00) | 18.7374 |
| 1990's | 13 (52.00) | 18.2507 |
| 2000's | 8 (32.00) | 29.6817 |
| 2010's | 3 (12.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciafaloni, E; DiGuiseppi, C; James, K; Lamb, MM; Ouyang, L; Pandya, S; Weitzenkamp, D; West, NA; Yang, M | 1 |
| Cwik, V; Dubow, JS; Fehlings, DL; Florence, JM; Greenberg, CR; Griggs, RC; King, W; Kissel, JT; Mendell, JR; Meyer, JM; Miller, JP; Moxley, RT; Pandya, S; Pestronk, A; Vanasse, M | 1 |
| Collins, J; Cripe, LH; Hor, KN; Rose, SR; Rutter, MM; Sawnani, H; Sucharew, H; Wong, BL; Woo, JG | 1 |
| Carbajo, S; Carbajo-Pérez, E; Chan, JC; Krieg, RJ; Latta, K | 1 |
| Alman, B; Biggar, WD; Comi, LI; Harris, VA; Nigro, G; Palladino, A; Passamano, L; Politano, L; Vajsar, J | 1 |
| Balaban, B; Carry, T; Clayton, GH; Matthews, DJ | 1 |
| Alman, B; Biggar, WD; Eliasoph, L; Harris, VA | 1 |
| Alonso, G; Ferraris, JR; Galich, AM; Jasper, H; Legal, S; Pasqualini, T; Sorroche, P | 1 |
| Bérubé, D; Brousseau, Y; D'Arcy, S; Dubé, J; Filiatrault, M; Fournier, A; Houde, S; Lapierre, G; Vanasse, M | 1 |
| Beneton, M; Guilland-Cumming, DF; Harvey, L; Imbimbo, B; Kanis, JA; Russell, RG | 1 |
| Chan, JC; Chan, W; Hisano, S; Krieg, RJ; Latta, K | 1 |
| Coirini, H; De Nicola, AF; Flores, D; Gonzalez Deniselle, MC; Vega, MC | 1 |
| Eberhardt, R; Gross, W; Krüger, K; Reiter, W; Zwingers, T | 1 |
| Angelini, C; Costa, C; Intino, MT; Pegoraro, E; Pini, A; Turella, E | 1 |
| Aicardi, G; Benso, L; Coppo, R; Cordone, G; Di Battista, E; Sardella, ML; Sernia, O; Terragna, A; Verrina, E; Vignolo, M | 1 |
| Reitter, B | 1 |
| Han, DS; Kim, MS; Kim, SI; Kim, YS; Lee, HY; Lim, SK; Park, K | 1 |
| Broyer, M; Gagnadoux, MF; Guest, G; Lehnert, A; Niaudet, P; Terzi, F | 1 |
| Imbimbo, B; Milani, S; Riboldi, A; Rizzato, G; Torresin, A | 1 |
| Feneberg, R; Klaus, G; Mehls, O; Paschen, C; Schaefer, F; Schärer, K; Wüster, C | 1 |
| Biggar, WD; Fehlings, DL; Gingras, M; Harris, VA; Steele, CA | 1 |
| Fainstein Day, P; Ferraris, JR; Granillo, E; Gutman, R; Pasqualini, T; Ramirez, J; Ruiz, S | 1 |
| Allen, R; Ansell, BM; David, J; Green, JR; Hesp, R; Loftus, J; Reeve, J; Reid, DM; Woo, PM; Wright, DJ | 1 |
| Aicardi, G; Coppo, R; Cordone, G; Cottafava, F; Di Battista, E; Gusmano, R; Imbimbo, B; Milani, S; Terragna, A; Vignolo, M | 1 |
| Di Palo, FQ; Elli, A; Mascaretti, L; Palazzi, P; Parenti, M; Puglisi, G; Rivolta, R; Sioli, V | 1 |
15 trial(s) available for deflazacort and Body Weight
| Article | Year |
|---|---|
Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.
Topics: Adolescent; Anti-Inflammatory Agents; Body Weight; Child; Child, Preschool; Double-Blind Method; Humans; Least-Squares Analysis; Male; Motor Activity; Muscle Strength; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Treatment Outcome | 2016 |
Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols.
Topics: Adolescent; Body Height; Body Weight; Calcium; Case-Control Studies; Cataract; Child; Clinical Protocols; Dietary Supplements; Drug Administration Schedule; Follow-Up Studies; Fractures, Bone; Humans; Immunosuppressive Agents; Male; Motor Activity; Muscular Dystrophy, Duchenne; Pregnenediones; Psychomotor Performance; Scoliosis; Treatment Outcome; Vitamin D | 2004 |
Effects of deflazacort vs. methylprednisone: a randomized study in kidney transplant patients.
Topics: Adipose Tissue; Body Composition; Body Mass Index; Body Weight; Child; Cholesterol; Cholesterol, LDL; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Transplantation; Lipids; Methylprednisolone; Pregnenediones; Prospective Studies | 2007 |
Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Body Height; Body Weight; Bone Density; Cataract; Fractures, Bone; Humans; Longitudinal Studies; Male; Muscular Dystrophy, Duchenne; Pregnenediones; Scoliosis; Treatment Outcome | 2008 |
Long-term therapy with the new glucocorticosteroid deflazacort in rheumatoid arthritis. Double-blind controlled randomized 12-months study against prednisone.
Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Body Weight; Cushing Syndrome; Double-Blind Method; Electrocardiography; Female; Hormones; Humans; Immunoglobulins; Male; Middle Aged; Prednisone; Pregnenediones | 1994 |
Deflazacort in Duchenne dystrophy: study of long-term effect.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Child; Double-Blind Method; Follow-Up Studies; Gait; Humans; Motor Activity; Muscles; Muscular Dystrophies; Patient Dropouts; Pregnenediones; Time Factors | 1994 |
Dose-dependent effects of deflazacort and prednisone on growth and skeletal maturation.
Topics: Age Determination by Skeleton; Anti-Inflammatory Agents; Body Height; Body Weight; Child; Child, Preschool; Connective Tissue Diseases; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Kidney Diseases; Male; Prednisone; Pregnenediones | 1993 |
Deflazacort vs. prednisone in Duchenne muscular dystrophy: trends of an ongoing study.
Topics: Alkaline Phosphatase; Anti-Inflammatory Agents; Body Weight; Child; Child, Preschool; Creatine Kinase; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Male; Muscle Contraction; Muscular Dystrophies; Neurology; Prednisone; Pregnenediones | 1995 |
Post-transplantation diabetes is better controlled after conversion from prednisone to deflazacort: a prospective trial in renal transplants.
Topics: Adult; Blood Glucose; Body Weight; Diabetes Mellitus; Female; Glycated Hemoglobin; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Pregnenediones; Prospective Studies | 1997 |
A controlled study of deflazacort in the treatment of idiopathic nephrotic syndrome.
Topics: Adolescent; Body Height; Body Weight; Bone Density; Child; Female; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Pregnenediones | 1997 |
The long-term efficacy and safety of two different corticosteroids in chronic sarcoidosis.
Topics: Adult; Analysis of Variance; Anti-Inflammatory Agents; Body Weight; Bone Density; Chronic Disease; Data Interpretation, Statistical; Drug Administration Schedule; Female; Humans; Lung Diseases; Male; Middle Aged; Prednisolone; Pregnenediones; Prospective Studies; Sarcoidosis; Time Factors | 1997 |
Experience with deflazacort in children and adolescents after renal transplantation.
Topics: Adipose Tissue; Adolescent; Blood Pressure; Body Height; Body Weight; Bone Density; Child; Female; Growth; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Male; Pregnenediones | 2000 |
Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.
Topics: Adolescent; Anti-Inflammatory Agents; Arthritis, Juvenile; Body Height; Body Weight; Bone Density; Child; Child, Preschool; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Prednisone; Pregnenediones | 1991 |
Comparison of growth retarding effects induced by two different glucocorticoids in prepubertal sick children: an interim long-term analysis.
Topics: Age Determination by Skeleton; Body Height; Body Weight; Child; Child, Preschool; Connective Tissue Diseases; Female; Glomerulonephritis; Growth Disorders; Humans; Linear Models; Longitudinal Studies; Male; Prednisone; Pregnenediones; Puberty; Random Allocation | 1991 |
Deflazacort versus 6-methylprednisolone in renal transplantation: immunosuppressive activity and side effects.
Topics: Adult; Anti-Inflammatory Agents; Blood Glucose; Body Weight; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Pregnenediones; Random Allocation | 1990 |
10 other study(ies) available for deflazacort and Body Weight
| Article | Year |
|---|---|
Corticosteroid Treatment and Growth Patterns in Ambulatory Males with Duchenne Muscular Dystrophy.
Topics: Adolescent; Body Height; Body Mass Index; Body Weight; Case-Control Studies; Child; Child, Preschool; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Male; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones | 2016 |
Growth hormone treatment in boys with Duchenne muscular dystrophy and glucocorticoid-induced growth failure.
Topics: Body Height; Body Weight; Child; Glucocorticoids; Growth Disorders; Human Growth Hormone; Humans; Male; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Treatment Outcome | 2012 |
Effects of deflazacort and cortisone on cellular proliferation in the rat thymus.
Topics: Animals; Anti-Inflammatory Agents; Antimetabolites; Body Weight; Bromodeoxyuridine; Cell Division; Cortisone; Histocytochemistry; Organ Size; Pregnenediones; Rats; Rats, Long-Evans; S Phase; Thymus Gland | 2002 |
Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect.
Topics: Adolescent; Anti-Inflammatory Agents; Body Height; Body Weight; Disease Progression; Dose-Response Relationship, Drug; Follow-Up Studies; Glucocorticoids; Humans; Male; Motor Activity; Motor Skills; Muscle Weakness; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Retrospective Studies; Statistics, Nonparametric | 2005 |
Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade.
Topics: Adolescent; Body Height; Body Weight; Cataract; Child; Humans; Immunosuppressive Agents; Lung; Male; Motor Activity; Muscular Dystrophy, Duchenne; Posture; Pregnenediones; Quality of Life; Respiratory Function Tests; Retrospective Studies; Stroke Volume; Treatment Outcome; Walking | 2006 |
Deflazacort and skeletal, phosphate and glucose metabolism in monkeys.
Topics: Alkaline Phosphatase; Animals; Blood Glucose; Body Weight; Bone and Bones; Creatinine; Female; Hydroxyproline; Macaca fascicularis; Male; Organ Size; Phosphates; Pregnenediones | 1984 |
Effects of deflazacort and cortisone on body growth, thymus weight and gene expression of growth-related proteins in the rat.
Topics: Animals; Body Weight; Cortisone; Eating; Gene Expression; Growth Substances; Insulin-Like Growth Factor I; Organ Size; Pregnenediones; Rats; Rats, Inbred Strains; Receptors, Somatotropin; RNA, Messenger; Thymus Gland | 1994 |
Binding of the anti-inflammatory steroid deflazacort to glucocorticoid receptors in brain and peripheral tissues. In vivo and in vitro studies.
Topics: Animals; Anti-Inflammatory Agents; Binding, Competitive; Body Weight; Brain; Cerebral Cortex; Corticosterone; Dexamethasone; Hippocampus; In Vitro Techniques; Liver; Male; Methylprednisolone; Organ Size; Ornithine Decarboxylase; Pituitary Gland, Anterior; Prednisone; Pregnenediones; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Thymus Gland | 1994 |
Deflazacort treatment of Duchenne muscular dystrophy.
Topics: Activities of Daily Living; Adolescent; Anti-Inflammatory Agents; Body Height; Body Weight; Cataract; Child; Humans; Male; Motor Skills; Muscular Dystrophy, Duchenne; Pregnenediones; Retrospective Studies; Treatment Outcome; Vital Capacity; Walking | 2001 |
Effect of therapy with a new glucocorticoid, deflazacort, on linear growth and growth hormone secretion after renal transplantation.
Topics: Body Height; Body Weight; Child; Child, Preschool; Female; Growth; Growth Hormone; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Pregnenediones | 1992 |